The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations
Open accessAbstract
Commercialization of protein‐based therapeutics is a challenging task in part due to the difficulties in maintaining protein solutions safe and efficacious throughout the drug product development process, storage, transportation and patient administration. Bulk drug substance goes through a series of formulation, fill and finish operations to provide the final dosage form in the desired formulation and container or delivery device. Different process parameters during each of these operations can affect the purity, activity and efficacy of the final product. Common protein degradation pathways and the various physical and chemical factors that can induce such reactions have been extensively studied for years. This review presents an overview of the various formulation‐fill‐finish operations with a focus on processing steps and conditions that can impact product quality. Various manufacturing operations including bulk freeze‐thaw, formulation, filtration, filling, lyophilization, inspection, labeling, packaging, storage, transport and delivery have been reviewed. The article highlights our present day understanding of protein instability issues during biopharmaceutical manufacturing and provides guidance on process considerations that can help alleviate these concerns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Privalov, P. L. (1990) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239009090612 · Cited by 1,071
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice
Tang, X., & Pikal, M. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016234.73023.75 · Cited by 972
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Principles of protein folding, misfolding and aggregation
Dobson, C. M. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.008 · Cited by 904
Oxidation of methionyl residues in proteins: Tools, targets, and reversal
Vogt, W. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00158-g · Cited by 883
Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
Carpenter, J. F., Pikal, M. J., Chang, B. S., & Randolph, T. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012180707283 · Cited by 683
Factors affecting short-term and long-term stabilities of proteins
Arakawa, T., Prestrelski, S. J., Kenney, W. C., & Carpenter, J. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00144-7 · Cited by 640
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Surface-Induced Denaturation of Proteins during Freezing and its Inhibition by Surfactants
Chang, B. S., Kendrick, B. S., & Carpenter, J. F. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960080y · Cited by 476
Cited by
Improving Protein Expression, Stability, and Function with ProteinMPNN
(2024) · doi:10.1021/jacs.3c10941 · Cited by 344
Corchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., et al. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.001 · Cited by 133
Correia, M., Neves-Petersen, M. T., Jeppesen, P. B., Gregersen, S., & Petersen, S. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050733 · Cited by 132
Metadata
- Authors
- Rathore, N., & Rajan, R. S.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2008-05
- Volume
- 24
- Issue
- 3
- Pages
- 504-514
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2118107894
- Cited by
- 289
- References
- 47
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations. https://app.cochat.ai/papers/10.1021/bp070462h
- The paper
- Rathore, N., & Rajan, R. S. (2008). Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations. Biotechnology Progress. https://doi.org/10.1021/bp070462h
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.